Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- TBI
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
MouseTBIClosed-head / concussionC57BL/6Malen = Four groups, n=5-7 per groupIntraperitoneal, solubilised in 0.5% dimethyl sulfoxide in saline40 or 100 mg/kg1 h after injury
Model: Closed-skull mild traumatic brain injury created by thinning a 2.0 x 2.0 mm cranial window over the left somatosensory cortex to 20-30 um and pressing the pliable bone downward 0.5 mm
C53N at 40 or 100 mg/kg given 1 h after injury reduced parenchymal cell death at 6 and 12 h, lesion size and brain water content at 24 h, lowered hydrogen peroxide and reduced glial reactivity.
Extraction: extract · Subtype source: llm · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.